Pharmacogenetics – Leveraging genetics to improve patient treatment and reduce spending

Pharmacogenetics – Leveraging genetics to improve patient treatment and reduce spending

May 26, 2022 12:00 PM to 1:00 PMOnline - Saskatchewan Time
Area of Interest: Pensions, Benefits, Investments, Networking Format: Web

An online seminar hosted by CPBI Saskatchewan

 

Please join us for an online seminar on May 26, 2022.

 

Pharmacogenetics is increasingly being used by healthcare providers to improve the safety and effectiveness of medications. This medical advancement aims not to treat the patient as a statistic but rather as an individual with unique characteristics that make them more or less suited to take certain medications. As mental health issues become amplified within the current global context, providers of healthcare management services are looking for medical innovations to maximize the efficiency of patient treatments. With its ease of use and demonstrated benefit, pharmacogenomics has positioned itself as a stepping-stone towards integrating precision medicine in medication therapy management programs.

Cancellation Policy

This session will be presented by:

 

Michel Cameron
Assistant Director – Pharmacogenomics
BIOGENIQ 

Michel Cameron did his PhD in pharmacology at the Sainte-Justine children’s Hospital in Montreal, where he studied the genetics of congenital heart malformations. Driven by his interest in pharmacogenetics, he joined the startup Biogeniq in 2014 as one of their founding members while undertaking post-doctoral studies in pharmacogenomics at the Montreal Heart Institute. 

Biogeniq was the first Canadian company to specialise in delivering genetic testing to medical clinics. Acquired in 2018 by the Biron Health Group, Biogeniq continues to promote the use of personalized medicine by offering pharmacogenetic tests that improve the effectiveness and safety of medications. Since joining Biogeniq, Michel has continued to work in developing clinically relevant and useful pharmacogenetic tests in collaboration with healthcare professionals across Canada. He also plays an important role in educating healthcare professionals on how to integrate pharmacogenetics in their practice. 
  
  

Learning objectives:

  1. Understand how pharmacogenetics can result in better patient care
  2. Recognize the potential cost-savings with pharmacogenetics
  3. Describe the challenges and possible barriers of implementing pharmacogenetics
  4. Present examples of real-life patients who have benefited from pharmacogenetics

 

When

Thursday May 26, 2022
12:00 pm - 1:00 pm SK - Presentation
Questions and CE credit quiz to follow

 

Registration Fee

CPBI Members: $20                        
Future Members: $55 
Virtual Table of 4: $80/$220
Virtual Table of 6: $100/$275

 
     
 

Where

Online Session

Access information will be sent to all registrants one day in advance of the online session. For virtual tables, the names and email addresses of table attendees must be submitted 72 hours prior to the event in order to receive the access information. Please plan to log in 10 minutes prior to the start of the session. This session will be recorded and available to registrants.

 

Who Should Attend:

Plan Sponsors
Human Resource Decision Makers
Human Resource Professionals
Retirement Professionals
Consultants and Brokers
Insurers and Plan Providers
Case Managers 

 
     
 

CE Credit: 

This session qualifies for 1 Continuing Education credit for the Insurance Council of Saskatchewan (one credit per hour). You will be required to complete a short quiz at the end of the online session to qualify for continuing education credits.

 

Questions

Krista Frayn
Phone: (888) 788-3185
[email protected]

 
     
     

Kim Duxbury

Brokers, advisors, consultants, HR personnel and insurers who are involved with drug benefits for employee plans.
By continuing to use this website, you are agreeing to our use of cookies.